IART.US Integra LifeSciences Holdings

Healthcare Health Care Equipment & Supplies USA Stocks
14.40 USD
Close of Nov 15, 2026
8.70 20.49
Market cap
USD 1.12B
P/E
84.7x
P/B
0.45x
ROE
1.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is IART.US undervalued?

Graham number
Price14.40
Graham value11.02
Premium30.7%

IART.US trades 30.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Integra LifeSciences Holdings fundamental analysis

No fundamental analysis for Integra LifeSciences Holdings yet.

Integra LifeSciences Holdings stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Integra LifeSciences Holdings

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitori…

Full company profile